Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Risk and prognostic factors for acute GVHD based on NIH consensus criteria

Bone Marrow Transplantation volume 48, pages 587–592 (2013)Cite this article

Subjects

Abstract

To investigate the risk factors for acute GVHD (aGVHD), based on NIH consensus criteria (NCC), we evaluated 775 patients who underwent allogeneic transplantation. Of them, 346 patients developed aGVHD by NCC, in whom we also analyzed factors affecting aGVHD-specific survival. The cumulative incidence of aGVHD was 44.7%, consisting of classic aGVHD (n=320) and late-onset (n=26). Multivariate analyses revealed that younger age (P=0.015), unrelated donors (P=0.004) and acute leukemia compared with other hematologic malignancies (P=0.005) were significant risk factors for aGVHD, whereas PBSCs showed no association (P=0.720). Multivariate analyses, with only aGVHD patients, revealed that late-onset aGVHD had superior aGVHD-specific survival to classic aGVHD (P=0.044), and identified the association of visceral organ involvement (P=0.002), severity of aGVHD at onset (P=0.035) and advanced disease status (P<0.001) with inferior aGVHD-specific survival. In conclusion, this study demonstrates the risk and prognostic factors for aGVHD by NCC with some differences with the previous reports that were based on old criteria. The difference in the risk factors according to different criteria will give insights about the pathophysiology of GVHD. The better prognosis of late-onset aGVHD than of classic aGVHD raises the necessity for prospective trials with a large cohort focusing on the onset time.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397–406.

    Article  CAS  PubMed  Google Scholar 

  2. Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197–1203.

    Article  CAS  PubMed  Google Scholar 

  3. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838–1845.

    CAS  PubMed  Google Scholar 

  4. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043–2051.

    Article  CAS  PubMed  Google Scholar 

  5. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576–4583.

    Article  CAS  PubMed  Google Scholar 

  6. Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 2007; 13: 1461–1468.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hahn T, McCarthy PL, Zhang MJ, Wang D, Arora M, Frangoul H et al. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol 2008; 26: 5728–5734.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  PubMed  Google Scholar 

  9. Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011; 117: 3214–3219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Min CK, Kim SY, Lee MJ, Eom KS, Kim YJ, Kim HJ et al. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation. Bone marrow transplant 2006; 38: 149–156.

    Article  CAS  PubMed  Google Scholar 

  11. Cho BS, Lee SE, Song HH, Lee JH, Yahng SA, Eom KS et al. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health Consensus Criteria and Associated Outcomes. Biol Blood Marrow Transplant 2012; 18: 1136–1143.

    Article  PubMed  Google Scholar 

  12. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on acute GVHD grading. Bone marrow transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  13. Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215–233.

    Article  CAS  PubMed  Google Scholar 

  14. Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone marrow transplant 2008; 41: 813–820.

    Article  PubMed  Google Scholar 

  15. Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009; 23: 78–84.

    Article  PubMed  Google Scholar 

  16. Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008; 14: 748–758.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Eisner MD, August CS . Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone marrow transplant 1995; 15: 663–668.

    CAS  PubMed  Google Scholar 

  18. Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012; 119: 296–307.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465–1470.

    CAS  PubMed  Google Scholar 

  20. Korbling M, Anderlini P . Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 2001; 98: 2900–2908.

    Article  CAS  PubMed  Google Scholar 

  21. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH . Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685–3691.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110026368).

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

    S-E Lee, B-S Cho, J-H Kim, J-H Yoon, S-H Shin, S-A Yahng, K-S Eom, Y-J Kim, H-J Kim, S Lee, C-K Min, S-G Cho, D-W Kim, J-W Lee, W-S Min & C-W Park

Authors
  1. S-E Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B-S Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J-H Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J-H Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S-H Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S-A Yahng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K-S Eom
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Y-J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H-J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. C-K Min
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. S-G Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. D-W Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. J-W Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. W-S Min
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. C-W Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B-S Cho.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, SE., Cho, BS., Kim, JH. et al. Risk and prognostic factors for acute GVHD based on NIH consensus criteria. Bone Marrow Transplant 48, 587–592 (2013). https://doi.org/10.1038/bmt.2012.187

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.187

Keywords

This article is cited by

Search

Advanced search

Quick links